Epidemiology of benign breast disease, with special attention to histologic types.
暂无分享,去创建一个
[1] T. Rohan,et al. Dietary fiber and risk of benign proliferative epithelial disorders of the breast , 1995, International journal of cancer.
[2] and Oral Contraceptives , 1995 .
[3] P. Ghadirian,et al. Nutritional profile of women with fibrocystic breast disease. , 1993, International journal of epidemiology.
[4] C. Bodian. Benign breast diseases, carcinoma in situ, and breast cancer risk. , 1993, Epidemiologic reviews.
[5] P. Ghadirian,et al. Case-control study of fibrocystic breast disease. , 1993, Revue d'epidemiologie et de sante publique.
[6] G R Howe,et al. Risk factors for fibroadenoma: a case-control study in Australia. , 1992, American journal of epidemiology.
[7] H. Le. Benign breast disorders: the clinician's view. , 1992 .
[8] L. Hughes. Benign breast disorders: the clinician's view. , 1992, Cancer detection and prevention.
[9] D. Ingram,et al. The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. , 1991, British Journal of Cancer.
[10] C. la Vecchia,et al. Smoking habits and risk of benign breast disease. , 1991, International journal of epidemiology.
[11] A. Howell,et al. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast , 1991, International journal of cancer.
[12] J. Potter,et al. A case-control study of diet and benign proliferative epithelial disorders of the breast. , 1990, Cancer research.
[13] P. Band,et al. Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. , 1990, American journal of epidemiology.
[14] A. Simard,et al. Nutrition and lifestyle factors in fibrocystic disease and cancer of the breast. , 1990, Cancer detection and prevention.
[15] J. Baron,et al. Cigarette smoking and benign proliferative epithelial disorders of the breast in women: a case-control study. , 1989, Journal of epidemiology and community health.
[16] K. McPherson,et al. Oral contraceptive use influences resting breast proliferation. , 1989, Human pathology.
[17] T. Rohan,et al. Methylxanthines and benign proliferative epithelial disorders of the breast in women. , 1989, International journal of epidemiology.
[18] D. Ingram,et al. Obesity and breast disease. The role of the female sex hormones , 1989, Cancer.
[19] B. Modan,et al. Nutritional factors associated with benign breast disease etiology: a case-control study. , 1989, The American journal of clinical nutrition.
[20] I. Ellis,et al. In situ carcinoma of the breast. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] A. Morrison,et al. Histologic and mammographic specificity of risk factors for benign breast disease , 1989, Cancer.
[22] T. Rohan,et al. Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women , 1989, International journal of cancer.
[23] S. Schnitt,et al. In situ carcinoma of the breast. , 1989, Annual review of medicine.
[24] J. Kelsey,et al. Fibroadenoma and the use of exogenous hormones. A case-control study. , 1988, American journal of epidemiology.
[25] C. Alderman. Benign breast disease. , 1988, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[26] T. Anderson,et al. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. , 1988, The American journal of pathology.
[27] R. Mansel,et al. ABERRATIONS OF NORMAL DEVELOPMENT AND INVOLUTION (ANDI): A NEW PERSPECTIVE ON PATHOGENESIS AND NOMENCLATURE OF BENIGN BREAST DISORDERS , 1987, The Lancet.
[28] C. Key,et al. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.
[29] J. A. Andersen,et al. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. , 1987, British Journal of Cancer.
[30] V. Ernster,et al. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk , 1987, International journal of cancer.
[31] V. Ernster,et al. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. , 1987, Journal of the National Cancer Institute.
[32] J. Kelsey,et al. Estrogen replacement therapy and fibrocystic breast disease. , 1987, American journal of preventive medicine.
[33] J. Russo,et al. Influence of age and gland topography on cell kinetics of normal human breast tissue. , 1987, Journal of the National Cancer Institute.
[34] A. Walker,et al. Conjugated estrogens and fibrocystic breast disease. , 1986, American Journal of Epidemiology.
[35] Godfrey Se. Is 'fibrocystic disease' of the breast precancerous? , 1986, Archives of pathology & laboratory medicine.
[36] R. Frisch,et al. Lower prevalence of benign diseases of the breast and benign tumours of the reproductive system among former college athletes compared to non-athletes. , 1986, British Journal of Cancer.
[37] J. Kelsey,et al. Cigarette smoking and benign breast disease. , 1985, Journal of epidemiology and community health.
[38] C. Alpers,et al. The prevalence of carcinoma in situ in normal and cancer-associated breasts. , 1985, Human pathology.
[39] J. Kelsey,et al. Risk factors for fibrocystic breast disease and its histopathologic components. , 1985, Journal of the National Cancer Institute.
[40] David L. Page,et al. Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study , 1985, Cancer.
[41] C. la Vecchia,et al. Benign breast disease and consumption of beverages containing methylxanthines. , 1985, Journal of the National Cancer Institute.
[42] T. Rohan,et al. The patho‐epidemiology of benign proliferative epithelial disorders of the female breast , 1985, The Journal of pathology.
[43] E. Ron,et al. A case-control study of caffeine and methylxanthines in benign breast disease. , 1985, JAMA.
[44] T. K. Hunt,et al. Vitamin E and benign breast "disease": a double-blind, randomized clinical trial. , 1985, Surgery.
[45] J. Kelsey,et al. An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia. , 1985, American journal of epidemiology.
[46] G. Beck,et al. Estrogen replacement therapy and fibrocystic breast disease in postmenopausal women. , 1985, American journal of epidemiology.
[47] R. Brown,et al. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. , 1985, British Journal of Cancer.
[48] W D Dupont,et al. Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.
[49] R. London,et al. The Effect of Vitamin E on Mammary Dysplasia: A Double‐Blind Study , 1985, Obstetrics and gynecology.
[50] R. Hoover,et al. Estrogen replacement therapy and benign breast disease. , 1984, Journal of the National Cancer Institute.
[51] J. Kelsey,et al. Exogenous hormone use and fibrocystic breast disease by histopathologic component , 1984, International journal of cancer.
[52] M. King,et al. Risk factors for benign breast disease: a case-control study of discordant twins. , 1984, American journal of epidemiology.
[53] C. la Vecchia,et al. Oral contraceptives and benign breast disease: a case-control study. , 1984, American journal of obstetrics and gynecology.
[54] C. la Vecchia,et al. Risk factors for pathologically confirmed benign breast disease. , 1984, American journal of epidemiology.
[55] J. Kelsey,et al. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women. , 1984, American journal of epidemiology.
[56] J. Kelsey,et al. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. , 1984, Journal of the National Cancer Institute.
[57] B. Macmahon,et al. Age at first birth and breast atypia , 1984, International journal of cancer.
[58] W. Willett,et al. Diet and cancer--an overview (second of two parts). , 1984, The New England journal of medicine.
[59] B. Macmahon,et al. Oral contraceptive use and fibrocystic breast disease of different histologic classifications. , 1984, Journal of the National Cancer Institute.
[60] M. Nielsen,et al. Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women , 1984, Cancer.
[61] J. Azzopardi. Benign and malignant proliferative epithelial lesions of the breast; a review. , 1983, European journal of cancer & clinical oncology.
[62] S. Duffy,et al. Risk factors relevant to cystic breast disease: a case-control study. , 1983, Journal of epidemiology and community health.
[63] J. Kelsey,et al. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. , 1983, Journal of the National Cancer Institute.
[64] R. Brown,et al. Incidence of perilobular hemangioma in the female breast. , 1983, Archives of pathology & laboratory medicine.
[65] Leon Speroff,et al. Clinical gynecologic endocrinology and infertility , 1983 .
[66] S. Love,et al. Fibrocystic Disease of the Breast — A Nondisease? , 1982 .
[67] B. Armstrong,et al. The comparative epidemiology of benign breast lumps and breast cancer in Western Australia , 1982, International journal of cancer.
[68] S. Graham,et al. Caffeine consumption and benign breast disease: a case-control comparison. , 1982, American journal of public health.
[69] T. K. Hunt,et al. Effects of caffeine-free diet on benign breast disease: a randomized trial. , 1982, Surgery.
[70] D. Glebatis. "Risk factors for benign breast disease". , 1982, American journal of epidemiology.
[71] S. Love,et al. Sounding board. Fibrocystic "disease" of the breast--a nondisease? , 1982, The New England journal of medicine.
[72] K. Rothman,et al. Coffee and tea consumption and breast disease. , 1981, Surgery.
[73] M. Hakama,et al. Independent risk factors of benign and malignant breast lesions. , 1981, American Journal of Epidemiology.
[74] H. Abou-Issa,et al. Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease. , 1981, Surgery.
[75] S. Gart,et al. Measuring the effect of caffeine restriction on fibrocystic breast disease: the role of graphic stress telethermometry as an objective monitor of disease. , 1981, The Journal of reproductive medicine.
[76] J. Elwood,et al. Risk factors for benign breast disease: a 30-year cohort study. , 1981, Canadian Medical Association journal.
[77] V. Ernster. The epidemiology of benign breast disease. , 1981, Epidemiologic reviews.
[78] E. Cornish. METHYLXANTHINES AND BENIGN BREAST DISEASE , 1979, The Medical journal of Australia.
[79] Webster Dj,et al. Caffeine, cyclic nucleotides, and breast disease. , 1979, Surgery.
[80] H. Freeman,et al. Analysis of benign breast lesions in blacks. , 1979, American journal of surgery.
[81] R. Sitruk-Ware,et al. Benign Breast Disease I: Hormonal Investigation , 1979, Obstetrics and gynecology.
[82] J. Lindtner,et al. An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. , 1979, European journal of cancer.
[83] A. Lees,et al. Oral contraceptives and breast disease in premenopausal northern albertan women , 1978, International journal of cancer.
[84] D. Page,et al. Relation between component parts of fibrocystic disease complex and breast cancer. , 1978, Journal of the National Cancer Institute.
[85] J. Tonascia,et al. Benign and malignant breast tumours: epidemiological similarities. , 1978, International journal of epidemiology.
[86] J. Kelsey,et al. Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. , 1978, The New England journal of medicine.
[87] P. Cole,et al. Incidence rates and risk factors of benign breast neoplasms. , 1978, American journal of epidemiology.
[88] G. Stemmermann,et al. Volume and hyperplastic lesions of breasts of Japanese women in Hawaii and Japan. , 1978, Preventive medicine.
[89] B. Macmahon,et al. Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. , 1978, American journal of public health.
[90] J. Kelsey,et al. Oral contraceptives and breast disease. An epidemiological study. , 1978, American journal of epidemiology.
[91] J. Tonascia,et al. Epidemiologic characteristics of benign breast disease. , 1977, American journal of epidemiology.
[92] I. Mowszowicz,et al. Inadequate corpus luteal function in women with benign breast diseases. , 1977, The Journal of clinical endocrinology and metabolism.
[93] J. Meyer. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. , 1977, Human pathology.
[94] G. Comstock,et al. Benign breast tumor and estrogenic hormones: a population-based retrospective study. , 1976, American journal of epidemiology.
[95] B. Macmahon,et al. Oral contraceptives and reduced risk of benign breast diseases. , 1976, The New England journal of medicine.
[96] R. Paffenbarger,et al. Oral contraceptives as related to cancer and benign lesions of the breast. , 1975, Journal of the National Cancer Institute.
[97] H M Jensen,et al. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. , 1975, Journal of the National Cancer Institute.
[98] J. Kelsey,et al. A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use. , 1974, International journal of epidemiology.
[99] M. Chipman,et al. Breast feeding, family history, and breast disease. , 1974, American journal of epidemiology.
[100] Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. , 1974, The New England journal of medicine.
[101] K. Prechtel,et al. Der Einfluß oraler Steroidkontrazeptiva auf das Fibroadenom der Mamma* , 1973 .
[102] J. Tonascia,et al. Epidemiology of benign breast lesions: lack of association with oral contraceptive use. , 1973, The New England journal of medicine.
[103] B. Rush,et al. Mammary duct proliferation in the elderly. A histopathologic study , 1973, Cancer.
[104] M. Levy,et al. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme. , 1973, Lancet.
[105] R. Fechner. Benign breast disease in women on estrogen therapy. A pathologic study , 1972, Cancer.
[106] R. Doll,et al. Investigation of the possible relationship between oral contraceptives and benign and malignant breast disease , 1971, Cancer.
[107] H. Taylor. Oral contraceptives and pathologic changes in the breast , 1971, Cancer.
[108] R. Tank,et al. Multiple breast fibroadenomas in women on hormonal contraceptives. , 1971, The New England journal of medicine.
[109] R. Fechner. Fibrocystic disease in women receiving oral contraceptive hormones , 1970, Cancer.
[110] R. Fechner. Fibroadenomas in patients receiving oral contraceptives: a clinical and pathologic study. , 1970, American journal of clinical pathology.
[111] N. Mottet,et al. Florid breast fibroadenomas in patients taking hormonal oral contraceptives. , 1968, American journal of clinical pathology.
[112] L. Humphrey,et al. Histologic changes in clinically normal breasts at postmortem examination. , 1966, Archives of surgery.
[113] John B. Davis,et al. Cystic disease of the breast: Relationship to carcinoma , 1964, Cancer.
[114] A. Sandison. An autopsy study of the adult human breast: with special reference to proliferative epithelial changes of importance in the pathology of the breast. , 1962, National Cancer Institute monograph.
[115] Clagett Ot,et al. Incidence in Normal Breasts of Features Associated with Chronic Cystic Mastitis , 1957 .
[116] P. Sloss,et al. Incidence in normal breasts of features associated with chronic cystic mastitis. , 1957, The American journal of pathology.
[117] J. Pickren,et al. Incidence of chronic cystic disease in so‐called “normal breasts”. A study based on 225 postmortem examinations , 1951 .
[118] F. W. Foote,et al. COMPARATIVE STUDIES OF CANCEROUS VERSUS NONCANCEROUS BREASTS , 1945, Annals of surgery.
[119] E T BELL,et al. The Diseases of the Breast , 1925, Nature.